-+ 0.00%
-+ 0.00%
-+ 0.00%

Jyong Biotech Reports Positive Phase II Results for MCS-8 in Prostate Cancer Prevention and Metabolic Health

Reuters·02/12/2026 13:30:36

Please log in to view news